International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder

被引：96

作者：

Crunelle, Cleo L. ^{[1
,2
]}

van den Brink, Wim ^{[3
]}

Moggi, Franz ^{[4
]}

Konstenius, Maija ^{[5
]}

Franck, Johan ^{[5
]}

Levin, Frances R. ^{[6
]}

van de Glind, Geurt ^{[7
]}

Demetrovics, Zsolt ^{[8
]}

Coetzee, Corne ^{[9
]}

Luderer, Mathias ^{[10
]}

Schellekens, Arnt ^{[11
]}

Matthys, Frieda ^{[1
]}

机构：

[1] Univ Ziekenhuis Brussel UZ Brussel, Vrije Univ Brussel, Dept Psychiat, Brussels, Belgium

[2] Antwerp Univ, Toxicol Ctr, Antwerp, Belgium

[3] Univ Amsterdam, Acad Med Ctr, AIAR, Amsterdam, Netherlands

[4] Univ Bern, Univ Hosp Psychiat, Bern, Switzerland

[5] Karolinska Inst, Stockholm, Sweden

[6] Columbia Univ, New York State Psychiat Inst, New York, NY USA

[7] Univ Amsterdam, ICASA Fdn, Amsterdam, Netherlands

[8] Eotvos Lorand Univ, Budapest, Hungary

[9] Univ Limpopo, Dept Pharm, Sovenga, South Africa

[10] Heidelberg Univ, Dept Addict Behav & Addict Med, Cent Inst Mental Hlth, Med Fac Mannheim, Heidelberg, Germany

[11] Radboudumc, Dept Psychiat, Donders Inst Brain Cognit & Behav, NISPA, Nijmegen, Netherlands

来源：

EUROPEAN ADDICTION RESEARCH | 2018年 / 24卷 / 01期

关键词：

Attention deficit/hyperactivity disorder; Substance use disorders; Diagnosis; Treatment; Consensus; DEFICIT HYPERACTIVITY DISORDER; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; SELF-REPORT SCALE; ADULT ADHD; TREATMENT-SEEKING; DOUBLE-BLIND; NONMEDICAL USE; METHYLPHENIDATE;

D O I：

10.1159/000487767

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

Adult attention deficit/hyperactivity disorder (ADHD) often co-occurs with substance use disorders (SUD) and is associated with early onset and more severe development of SUD and with reduced treatment effectiveness. Screening tools allow for a good recognition of possible ADHD in adults with SUD and should be used routinely, followed by an ADHD diagnostic process initiated as soon as possible. Simultaneous and integrated treatment of ADHD and SUD, using a combination of pharmaco- and psychotherapy, is recommended. Long-acting methylphenidate, extended-release amphetamines, and atomoxetine with up-titration to higher dosages may be considered in patients unresponsive to standard doses. This paper includes evidence- and consensus-based recommendations developed to provide guidance in the screening, diagnosis and treatment of patients with ADHD-SUD comorbidity. (c) 2018 S. Karger AG, Basel

引用

页码：43 / 51

页数：9

共 50 条

[41] Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus
Young, Susan
Hollingdale, Jack
Absoue, Michael
Bolton, Patrick
Branney, Polly
Colley, William
Craze, Emily
Dave, Mayuri
Deeley, Quinton
Farrag, Emad
Gudjonsson, Gisli
Hill, Peter
Liang, Ho-Ian
Murphy, Clodagh
Mackintosh, Peri
Murin, Marianna
O'Regan, Fintan
Ougrin, Dennis
Rios, Patricia
Stover, Nancy
Taylor, Eric
Woodhouse, Emma
BMC MEDICINE, 2020, 18 (01)
[42] A Case Report of Concerta Misuse in a Patient with Comorbid Substance Use Disorder and Attention Deficit Hyperactivity Disorder
Rizkallah, Elie
Legault, Louis
Pampoulova, Tania
Levesque, Sylvie
Belanger, Michele
Stavro, Katherine
Chiasson, Jean-Pierre
Potvin, Stephane
AMERICAN JOURNAL ON ADDICTIONS, 2011, 20 (05) : 478 - 479
[43] Impact of Treatment with Central Nervous System Stimulant and Risk of Substance Use Disorder in Adults with Attention-Deficit/Hyperactivity Disorder
Jeun, Ki Jin
Al-Mamun, Mohammad
INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION, 2024,
[44] Why the Diagnosis of Attention Deficit Hyperactivity Disorder Matters
Hamed, Alaa M.
Kauer, Aaron J.
Stevens, Hanna E.
FRONTIERS IN PSYCHIATRY, 2015, 6
[45] Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia
Golubchik, Pavel
Sever, Jonathan
Weizman, Abraham
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (04) : 212 - 215
[46] Attention deficit hyperactivity disorder (ADHD) and substance use disorders
Wilson J.J.
Levin F.R.
Current Psychiatry Reports, 2001, 3 (6) : 497 - 506
[47] Attention-Deficit/Hyperactivity Disorder and Substance Abuse
Harstad, Elizabeth
Levy, Sharon
PEDIATRICS, 2014, 134 (01) : E293 - E301
[48] Delphi Consensus on Attention Deficit Hyperactivity Disorder (ADHD): evaluation by a panel of experts
Hervas, Amaia
de Santos, Teresa
Quintero, Javier
Ruiz-Lazaro, Pedro M.
Alda, Jose A.
Fernandez-Jaen, Alberto
Ramos-Quiroga, Josep A.
ACTAS ESPANOLAS DE PSIQUIATRIA, 2016, 44 (06): : 231 - 243
[49] Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric Comorbidity
Velez-Pastrana, Maria C.
Gonzalez, Rafael A.
Ramos-Fernandez, Alexandra
Padilla, Rafael R. Ramirez
Levin, Frances R.
Garcia, Carmen Albizu
EUROPEAN ADDICTION RESEARCH, 2020, 26 (4-5) : 179 - 190
[50] Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study
vanEmmerik-van Oortmerssen, Katelijne
van de Glind, Geurt
Koeter, Maarten W. J.
Allsop, Steve
Auriacombe, Marc
Barta, Csaba
Bu, Eli Torild H.
Burren, Yuliya
Carpentier, Pieter-Jan
Carruthers, Susan
Casas, Miguel
Demetrovics, Zsolt
Dom, Geert
Faraone, Stephen V.
Fatseas, Melina
Franck, Johan
Johnson, Brian
Kapitany-Foeveny, Mate
Kaye, Sharlene
Konstenius, Maija
Levin, Frances R.
Moggi, Franz
Moller, Merete
Ramos-Quiroga, J. Antoni
Schillinger, Arild
Skutle, Arvid
Verspreet, Sofie
van den Brink, Wim
Schoevers, Robert A.
ADDICTION, 2014, 109 (02) : 262 - 272

← 1 2 3 4 5 →